Literature DB >> 21139197

Structure of the iSH2 domain of human phosphatidylinositol 3-kinase p85β subunit reveals conformational plasticity in the interhelical turn region.

Curtis Schauder1, Li Chung Ma, Robert M Krug, Gaetano T Montelione, Rongjin Guan.   

Abstract

Phosphatidylinositol 3-kinase (PI3K) proteins actively trigger signaling pathways leading to cell growth, proliferation and survival. These proteins have multiple isoforms and consist of a catalytic p110 subunit and a regulatory p85 subunit. The iSH2 domain of the p85β isoform has been implicated in the binding of nonstructural protein 1 (NS1) of influenza A viruses. Here, the crystal structure of human p85β iSH2 determined to 3.3 Å resolution is reported. The structure reveals that this domain mainly consists of a coiled-coil motif. Comparison with the published structure of the bovine p85β iSH2 domain bound to the influenza A virus nonstructural protein 1 indicates that little or no structural change occurs upon complex formation. By comparing this human p85β iSH2 structure with the bovine p85β iSH2 domain, which shares 99% sequence identity, and by comparing the multiple conformations observed within the asymmetric unit of the bovine iSH2 structure, it was found that this coiled-coil domain exhibits a certain degree of conformational variability or `plasticity' in the interhelical turn region. It is speculated that this plasticity of p85β iSH2 may play a role in regulating its functional and molecular-recognition properties.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21139197      PMCID: PMC2998356          DOI: 10.1107/S1744309110041333

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  21 in total

Review 1.  The emerging mechanisms of isoform-specific PI3K signalling.

Authors:  Bart Vanhaesebroeck; Julie Guillermet-Guibert; Mariona Graupera; Benoit Bilanges
Journal:  Nat Rev Mol Cell Biol       Date:  2010-04-09       Impact factor: 94.444

2.  Mechanism of influenza A virus NS1 protein interaction with the p85beta, but not the p85alpha, subunit of phosphatidylinositol 3-kinase (PI3K) and up-regulation of PI3K activity.

Authors:  Yang Li; Deborah H Anderson; Qiang Liu; Yan Zhou
Journal:  J Biol Chem       Date:  2008-06-05       Impact factor: 5.157

3.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

4.  The high-throughput protein sample production platform of the Northeast Structural Genomics Consortium.

Authors:  Rong Xiao; Stephen Anderson; James Aramini; Rachel Belote; William A Buchwald; Colleen Ciccosanti; Ken Conover; John K Everett; Keith Hamilton; Yuanpeng Janet Huang; Haleema Janjua; Mei Jiang; Gregory J Kornhaber; Dong Yup Lee; Jessica Y Locke; Li-Chung Ma; Melissa Maglaqui; Lei Mao; Saheli Mitra; Dayaban Patel; Paolo Rossi; Seema Sahdev; Seema Sharma; Ritu Shastry; G V T Swapna; Saichu N Tong; Dongyan Wang; Huang Wang; Li Zhao; Gaetano T Montelione; Thomas B Acton
Journal:  J Struct Biol       Date:  2010-08-03       Impact factor: 2.867

5.  Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling.

Authors:  Benjamin G Hale; David Jackson; Yun-Hsiang Chen; Robert A Lamb; Richard E Randall
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-08       Impact factor: 11.205

6.  A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis.

Authors:  Ji-Young Min; Shoudong Li; Ganes C Sen; Robert M Krug
Journal:  Virology       Date:  2007-02-22       Impact factor: 3.616

7.  Binding of influenza A virus NS1 protein to the inter-SH2 domain of p85 suggests a novel mechanism for phosphoinositide 3-kinase activation.

Authors:  Benjamin G Hale; Ian H Batty; C Peter Downes; Richard E Randall
Journal:  J Biol Chem       Date:  2007-11-20       Impact factor: 5.157

8.  SH3 binding motif 1 in influenza A virus NS1 protein is essential for PI3K/Akt signaling pathway activation.

Authors:  Yeun-Kyung Shin; Yang Li; Qiang Liu; Deborah H Anderson; Lorne A Babiuk; Yan Zhou
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

9.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  4 in total

Review 1.  Crossroads of PI3K and Rac pathways.

Authors:  Carlo C Campa; Elisa Ciraolo; Alessandra Ghigo; Giulia Germena; Emilio Hirsch
Journal:  Small GTPases       Date:  2015-05-05

2.  A Comprehensive Survey of the Roles of Highly Disordered Proteins in Type 2 Diabetes.

Authors:  Zhihua Du; Vladimir N Uversky
Journal:  Int J Mol Sci       Date:  2017-09-21       Impact factor: 5.923

Review 3.  PI3K/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia (Review).

Authors:  Youbang Xie; Xuefeng Shi; Kuo Sheng; Guoxiong Han; Wenqian Li; Qiangqiang Zhao; Baili Jiang; Jianming Feng; Jianping Li; Yuhai Gu
Journal:  Mol Med Rep       Date:  2018-12-03       Impact factor: 2.952

4.  Suppressing Nonspecific Binding in Biolayer Interferometry Experiments for Weak Ligand-Analyte Interactions.

Authors:  Alyssa Dubrow; Bryan Zuniga; Elias Topo; Jae-Hyun Cho
Journal:  ACS Omega       Date:  2022-03-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.